Top Pharmaceutical Companies in Washington, DC (26)
Drug Information Association (DIA) is a leading global multidisciplinary life science membership association. It mobilizes life science professionals across all areas of expertise to engage with patients, peers, and thought leaders in a neutral environment. DIA focuses on the discovery, development, regulation, surveillance, and marketing of healthcare products to advance the life sciences community.
The National MS Society is a non-profit organization dedicated to curing multiple sclerosis while empowering people affected by the disease to live their best lives through research, education, and support.
ProPharma is the premier Research Consulting Organization (RCO), delivering fully customizable consulting solutions to empower biotech, med device, and pharmaceutical organizations of all sizes to advance scientific breakthroughs confidently and introduce new therapies. With over 20 years of expertise in regulatory sciences, clinical research solutions, quality & compliance, pharmacovigilance, medical information, and R&D technology, ProPharma partners with clients across the...
ProPharma's Top Stability & Growth Strengths
Market Expansion: Feedback suggests the company is broadening its global footprint, including opening a new office in Hyderabad and expanding across Central and Eastern Europe via acquisitions. These moves indicate a focus on scaling operations and accessing new markets.
Strategic Partnerships: Feedback suggests targeted acquisitions such as Clinres Farmacija and Digital Lab Consulting are used to enhance capabilities and geographic reach. These integrations appear to strengthen end-to-end service coverage across regulatory, clinical, and R&D functions.
Strong Brand Reputation: Feedback suggests multiple industry awards and recognitions, including CPHI and CRO Leadership distinctions, bolster standing as a top-tier provider. External analyst mentions, such as Everest Group’s PEAK Matrix designation, reinforce credibility.
We're transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet.
AstraZeneca's Top Stability & Growth Strengths
Strong Revenue Growth: Revenue is rising strongly, with 2024 up to $54.1B and continued momentum into 2025 alongside management’s stated 2030 ambition. The trend is broad‑based across oncology and biopharma, with repeated beats and reaffirmed guidance supporting durability.
Strong Market Position & Advantage: Market position is top‑tier globally by value and leadership is pronounced in oncology, where the company ranks among the top three by revenue with multiple anchor assets. Scale and execution in the U.S. and other key markets underline competitive advantage.
Innovation-Driven Growth: Pipeline and approvals are driving expansion, with multiple 2025 U.S. FDA wins for ADCs, an expanded first‑line label for Enhertu, and a deep ASCO 2025 presence across ADC, I/O, targeted agents, and SERD.
Bluesight enables hospital operations with intelligence that simplifies inventory management, procurement, and compliance. Through its suite of industry-leading, AI-powered solutions, Bluesight ensures that health systems protect every patient and optimize every dollar. Over 3,000 United States and Canadian hospitals rely on Bluesight every day. For more information, please visit bluesight.com. Bluesight's solutions include: KitCheck (inventory management), CostCheck (purchasing optimization), ControlCheck (diversion...
Bluesight's Top Stability & Growth Strengths
Strong Market Position & Advantage: Market leadership is reinforced by extensive adoption across 3,000+ hospitals and health systems in the U.S. and Canada and repeated Best in KLAS recognition for core categories. Category-leading positions in drug diversion monitoring, patient privacy monitoring, and RFID kit/tray management indicate sustained competitive advantage.
Innovation-Driven Growth: Ongoing launches such as the Prism AI platform and embedded generative capabilities for diversion investigations signal continuing innovation in pharmacy and compliance workflows. Additional releases like ShortageCheck, a redesigned 340B platform, and revenue optimization features broaden functionality and drive new use cases.
Strategic Partnerships: Collaborations with AWS, Premier, GraphiteRx/Mark Cuban Cost Plus Drugs, Pharma Logistics, Pfizer, and Healthmark are expanding distribution, capabilities, and ecosystem integration. These partnerships enable automated multi-product workflows and novel commercial arrangements that can accelerate adoption.
Established in 2001, Avalere Health is a purposefully built commercialization partner for the biopharmaceutical, medical technology, and wellness industries. Our team of 1,500+ experts combine their knowledge and expertise across our core disciplines—Consulting; Medical; Policy; Value, Evidence, and Access; Marketing; and Digital Experience Technology—to create the connections that make better health happen. We partner with our clients to navigate the...
Avalere Health's Top Stability & Growth Strengths
Resilient & Sustainable Growth: Revenue expanded in consecutive years, with double‑digit growth in 2023 followed by continued albeit slower growth in 2024. Trade coverage frames 2024 as a cooling market overall, suggesting the company’s trajectory reflects resilience amid a softer cycle.
Strong Market Position & Advantage: Industry rankings place the firm consistently in the MM+M Agency 100 top 20 in 2024–2025. External awards and frequent policy visibility reinforce stature in core North American healthcare‑agency and U.S. policy/access segments.
Future-Ready Strategy: Leadership additions, a unifying rebrand, and integration of advisory, medical, access, and marketing indicate a connected commercialization model. New offerings, AI/data‑driven tools, partnerships, and the “Every Patient Possible” mission signal preparation for evolving client needs.
RxAnte offers predictive analytics and targeted clinical programs that improve medication prescribing and adherence.
InGenesis, Inc. is a healthcare services firm specializing in workforce solutions and medical management services. Founded in 1998, its mission is to improve lives by connecting quality professionals—including nurses, physicians, and allied health practitioners—with purposeful work across healthcare, life sciences, higher education, and pharmaceutical industries. The company is recognized as a leading diversity supplier of healthcare workforce solutions in America.
InGenesis, Inc.'s Top Stability & Growth Strengths
Strong Market Position & Advantage: Market presence is characterized by recognition among the largest healthcare staffing firms and leadership accolades, suggesting a durable competitive standing in specialized healthcare workforce solutions.
Strategic Partnerships: Expansion through notable acquisitions such as Kelly Healthcare Resources and large-scale federal contracting vehicles reflects effective external alliances that extend service breadth and scale.
Strong Brand Reputation: Certifications like The Joint Commission Gold Seal and ISO 22956:2021, along with alignment to Baldrige principles, point to a reputation grounded in quality and operational rigor.
VytlOne is a national pharmacy and healthcare services provider focused on the cost-effective delivery of impactful care to patients and clients. Formerly Maxor, it offers integrated pharmacy solutions for health systems, including customized pharmacy management, 340B program expertise, specialty pharmacy, and PBA/PBM services. Its mission is to help hospitals, health systems, health centers, and employers unlock pharmacy revenue while improving...
Magellan Health is a leader in managing the fastest growing, most complex areas of health, including special populations, complete pharmacy benefits and other specialty areas of healthcare. Magellan supports innovative ways of accessing better health through technology, while remaining focused on the critical personal relationships that are necessary to achieve a healthy, vibrant life. Magellan's customers include health plans and...
AstraZeneca is a global, science-led, patient-focused biopharmaceutical company committed to excellence in the research, development, and commercialization of prescription medicines. With approximately 90,000 employees across 85 countries, the company aims to unlock the power of science to deliver innovative medicines that transform patient outcomes and improve healthcare for people, society, and the planet worldwide.
ASCP is the only international professional society devoted to optimal medication management and improved health outcomes for all older persons. Founded in 1969, ASCP is a non-profit membership organization currently based in Alexandria, VA. ASCP represents over 9,000 pharmacy professionals, including students, serving the unique medication needs of the senior population. Our members range in the services they provide and serve...
Sabin Vaccine Institute is a global nonprofit organization dedicated to making vaccines more accessible, enabling innovation, and expanding immunization across the globe. It develops impactful vaccines for unmet medical needs, fuels actionable research, champions data-driven advocacy, and strengthens immunization leadership, particularly in low- and middle-income countries, to protect the world's most vulnerable populations from vaccine-preventable infectious diseases.
PPD is now part of Thermo Fisher Scientific, the world leader in serving science. Together, Thermo Fisher and PPD are creating a unique opportunity to advance their shared pursuit to enable customers to make the world healthier by accelerating the development of new medicines. We now offer a comprehensive suite of world-class services across the clinical development spectrum – from...
The American Pharmacists Association (APhA) is the only organization advancing the entire pharmacy profession—helping pharmacists find success and satisfaction in their work while advocating for changes that benefit them and their patients. At APhA, we’re committed to helping pharmacists deliver outstanding patient care, receive due recognition, and work at a full scope of practice. As every pharmacist’s most powerful ally,...
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity and rare blood and endocrine disorders. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease. We are powered...
Novo Nordisk's Top Stability & Growth Strengths
Strong Market Position & Advantage: Novo Nordisk is characterized as a global leader in GLP‑1–based diabetes and obesity care, anchored by clinically differentiated products like Wegovy and a broad GLP‑1 portfolio. While shares fluctuate by geography, disclosures and independent analyses continue to frame the company as a category leader.
Innovation-Driven Growth: Cardiovascular outcomes data supporting Wegovy’s label expansion and the first approved oral GLP‑1 for chronic weight management, together with late‑stage assets (e.g., amycretin/zenagamtide, CagriSema), strengthen adoption arguments and extend the franchise.
Market Expansion: U.S. launch momentum for the Wegovy pill, EU approval, and planned international rollouts in 2026 are broadening access and the addressable market. Significant capacity additions, including acquired fill‑finish sites and new investments, are intended to support higher volumes across regions.
ERA Consulting offers consulting services and strategic advice in regulatory affairs and product development.
The Association for Accessible Medicines is driven by the belief that access to safe, quality, effective medicine has a tremendous impact on a person’s life and the world around them. Generic and biosimilar medicines improve people’s lives, improving society and the economy in turn. AAM represents the manufacturers and distributors of finished generic pharmaceuticals and biosimilars, manufacturers and distributors of...
When you donate blood plasma, you help create life-changing medicines, while putting a little extra money in your pocket at the same time.
